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Cell migration is an integral part of re-epithelialization during skin wound healing, 
a complex process involving molecular controls that are still largely unknown. 
Here we identify a novel role for Tcf3, an essential transcription factor regulating 
embryonic and adult skin stem cell functions, as a key effector of epidermal 
wound repair. We show that Tcf3 is upregulated in skin wounds and that Tcf3 
overexpression accelerates keratinocyte migration and skin wound healing. We 
also identify Stat3 as an upstream regulator of Tcf3.  Mechanistically, we show 
that the pro-migration effects of Tcf3 are non-cell autonomous and occur 
independently of its ability to interact with the canonical Wnt effector β-catenin.  
Finally, we identify Lipocalin-2 downstream of Tcf3 as the key secreted factor that 
promotes cell migration in vitro and wound healing in vivo. Our findings provide 
new insights into the molecular controls of wound-associated cell migration and 
identify potential therapeutic targets for the treatment of defective wound repair. 
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 Cutaneous wound repair is an essential regenerative process, which is required to 
maintain the barrier function of the skin after damage.  This regenerative process is 
complex with multiple steps that require dynamic interaction of many cell types1.  Wound 
healing proceeds in three partially overlapping phases: (1) inflammation, (2) re-
epithelialization, and (3) tissue remodeling. In the re-epithelialization step, epidermal 
cells migrate into the wound site, proliferate and differentiate to reform the epidermal 
barrier.  Defects in cell migration often lead to defective wound repair2-7.  Despite the 
importance of the re-epithelialization step in the wound healing process, our 
understanding of the molecular control of this crucial step is still lacking. 
 Tcf3 (also known as Tcf7l1) belongs to the Lef/Tcf family of transcription factors, 
all of which contain a highly conserved HMG domain that binds to a conserved 
recognition sequence, as well as domains that interact with the transcriptional activator 
β-catenin and Groucho/TLE-family corepressors.  Lef/Tcf members can function as 
repressors when bound to Groucho/TLE corepressors or as activators when bound to β-
catenin8,9.  In the absence of Wnt ligand, cytoplasmic β-catenin is phosphorylated by the 
Apc/Axin complex and targeted for degradation.  Binding of Wnt ligands to their surface 
receptors results in the sequestration of components of the Apc/Axin complex, 
preventing degradation of β-catenin and allowing its translocation into the nucleus.  In 
most cases, nuclear β-catenin interacts with Lef/Tcf members to activate transcription, 
converting them from corepressors into coactivators.  
 Tcf3 seems to be distinct from the other Lef/Tcf members. Although Tcf3 can bind 
to β-catenin, its major function throughout development appears to be Groucho/TLE-
dependent corepression of transcription10-14.  Tcf3 is expressed in many types of stem 
cells including embryonic stem cells11,15 and adult hematopoietic16,17, neural16,18 and skin 
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stem cells19,20.  Loss of function of Tcf3 leads to gastrulation defects and embryonic 
lethality21.  In skin, Tcf3 is expressed in embryonic epidermal cells and adult quiescent 
stem cells located in the hair follicle bulge region, as well as proliferative migrating stem 
cell progeny19,20.  Overexpression of Tcf3 in the epidermis blocks terminal differentiation 
and maintains cells in an undifferentiated state20,22.  The expression pattern of Tcf3 in 
skin is mirrored by its closely related paralog Tcf4 (also known as Tcf7l2), which appears 
to possess similar functions and can compensate for the absence of Tcf3 in skin 
development.  Loss of both Tcf3 and Tcf4 in skin results in hair follicle morphogenesis 
defects, as well as failure of re-epithelialization during wound repair and a loss of long-
term proliferation/self-renewal23.  
 Because the re-epithelialization process during wound repair depends on cell 
proliferation as well as migration, it is not clear whether Tcf3 has a role in controlling cell 
migration in addition to its established role in cell proliferation.  In this study, we aimed to 
investigate the role of Tcf3 in wound repair.  We found that Tcf3 promotes epidermal cell 
migration and accelerates wound healing. We also showed that Tcf3’s induction in 
response to wound stimuli is dependent on Stat3, a transcription factor that has 
previously been shown to be required for efficient wound repair.  Finally, we identified 
lipocalin 2 (Lcn2) as the critical downstream target of Tcf3 that promotes cell migration 
and wound healing. 
 
RESULTS 
 
Tcf3 is induced at the wound edge and its overexpression promotes cell migration 
in vitro 
Since the re-epithelialization process is defective in skin lacking Tcf3 and Tcf4, to 
explore Tcf3’s role in wound healing, we first examined the expression pattern of Tcf3 
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following full thickness skin wounding in young adult mice.  Within 3 days after 
wounding, Tcf3 is detectable at the wound edge in K5+ cells, with maximal expression 
levels by day 5 (Fig. 1A).  As expected, Tcf3 is not detectable at the wound edge in Tcf3 
conditional knockout skin.  Unlike Tcf3, other Lef/Tcf members are not induced at the 
wound edge, including Tcf4, which is otherwise expressed in a similar pattern to Tcf323.  
Lef1 and Tcf1 (also known as Tcf7), which have dissimilar expression patterns and 
functions to Tcf3 in adult skin, are also unaffected by wounding (Supplemental Fig. S1). 
 In the re-epithelialization step of the wound repair process, epidermal cells 
migrate into the wound site, proliferate and differentiate to reform the epidermal barrier1.  
To determine whether Tcf3 is involved in cell migration, we applied an established in 
vitro cell migration/wounding assay24 to uncouple cell migration from growth and 
differentiation effects.  In this assay, scratch “wounds” are created in monolayers of 
mitotically-inactivated mouse keratinocytes, and migration of keratinocytes into the 
scratch is then observed over time. To assess the effect of Tcf3 overexpression on 
migration, we first performed the assay with primary keratinocytes isolated from tet-
inducible Tcf3 (K14-rtTA;TRE-mycTcf3) transgenic mice22, which express a tightly 
regulated, strongly doxycycline-inducible Tcf3 transgene under the skin-specific keratin 
14 promoter (Supplemental Fig. S2).  We found that Tcf3-overexpressing keratinocytes 
showed an increase in cell migration of 60% compared with non-overexpressing controls  
(**p<0.001) (Fig. 1B, C), suggesting that Tcf3 can indeed functionally affect cell 
migration.  Using ex vivo explant skin culture, we also found epithelial cells from Tcf3-
induced skins migrated more than the control skins (**p<0.001) (Fig. 1D, E). 
 To determine whether the ability to promote cell migration is specific to Tcf3 or is a 
general characteristic of Lef/Tcf family members, we compared the effects of 
overexpression of all four Lef/Tcf members on cell migration.  We transduced 
keratinocytes with GFP-tagged, tet-inducible lentiviral vectors25 carrying myc-tagged 
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Tcf3, Tcf4, Lef1, or Tcf1 transgenes and enriched for transduced cells by fluorescent cell 
sorting.  We then used doxycycline (Dox) to induce the expression of the Lef/Tcf genes 
24 hours prior to performing the migration assay.  All four Lef/Tcf members were 
expressed at similar levels upon Dox treatment (Supplemental Fig. S3A). Of the four 
Lef/Tcf members, only Tcf3 and Tcf4 promoted cell migration (**p<0.001) (Supplemental 
Fig. S3B, C).  It is interesting to note that although Tcf4 is not induced at the wound 
edge in vivo, it does share the ability of Tcf3 to promote cell migration in this assay.  
 
Tcf3 overexpression in epidermal cells promotes wound healing in vivo 
Since overexpression of Tcf3 promotes cell migration in vitro, we wanted to determine 
whether Tcf3 expression could promote wound healing in vivo. We created full- 
thickness, 1 cm x 1 cm wounds on the dorsal skin of tet-inducible Tcf3 (K14-rtTA;TRE-
mycTcf3) (n=5) or control (K14-rtTA or TRE-mycTcf3) (n=5) mice that had been 
maintained on a doxycycline-containing diet.  We then measured the surface area of the 
wounds 6 and 10 days after wounding.  We saw that wound closure was significantly 
accelerated in Tcf3-induced mice relative to controls (*p<0.05) (Fig. 2A, B).  Accelerated 
wound repair was further confirmed by H&E staining of wound sections, which revealed 
much faster re-epithelialization in Tcf3-induced mice than controls (*p<0.05) (Fig. 2C, D). 
Expression of the Tcf3 transgene was verified by immunofluorescent staining for Tcf3 
(Supplemental Fig. S4A).  Overexpression of Tcf3 did not lead to an increase in Ki67 
staining at the wound edge (Supplemental Fig. S4B), suggesting that accelerated wound 
closure is mainly due to enhanced cell migration and not proliferation. Together with our 
previous finding that the loss of Tcf3 and Tcf4 causes defective wound repair23, our 
current finding that Tcf3 overexpression is sufficient to promote wound healing strongly 
suggests a critical role for Tcf3 in normal wound repair in vivo. 
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Tcf3 is induced at the wound edge in response to Stat3 signaling 
Next, we sought to identify factors that regulate Tcf3 expression in response to 
wounding.  We identified three evolutionarily conserved Stat3 binding sites in the Tcf3 
promoter (Supplemental Fig. S5), suggesting that Stat3 could potentially activate Tcf3 
transcription.  Stat3 is one of seven members of the STAT (Signal Transducer and 
Activator of Transcription) family of transcription factors, which remain latent in the 
cytoplasm at baseline. Upon activation by phosphorylation on its tyrosine residue 705, 
Stat3 dimerizes and translocates into the nucleus, where it binds to conserved 
consensus sites on target genes and activates their transcription26.  The role of Stat3 in 
promoting cell migration has been reported in numerous cases2,27, but the genes directly 
targeted by Stat3 to regulate cell migration are still largely unknown. 
 Given that Stat3 is induced at the skin wound edge and that its ablation has been 
shown to impair wound repair2, we next examined whether Stat3 regulates Tcf3 
expression in response to wounding. As expected, we found activated Stat3 at the 
wound edge, mirroring the pattern of Tcf3 induction (Fig. 3A, B). In contrast, in 
Stat3fl/fl;K14-Cre (Stat3 cKO) mice, where epidermal Stat3 is conditionally ablated28 by 
the epidermis-specific keratin 14 Cre driver29, Tcf3 failed to be induced at the skin wound 
edge  (Fig. 3C, D).  We obtained similar results by in situ hybridization for Tcf3 mRNA 
(Fig. 3E, F). Thus, these data suggest that Stat3 is necessary for Tcf3 upregulation 
during the wound response. 
 We next tested Stat3-mediated Tcf3 promoter activation by luciferase reporter 
assays, using a 5 kb Tcf3 promoter fragment cloned from genomic DNA. We found that 
constitutively activated Stat3 (Stat3C) induced reporter expression from the Tcf3 
promoter ; activation of the reporter was abolished by mutation of the Stat3 binding sites 
(*p<0.05) (Fig. 3G, H).  Lef1 and Tcf1 do not contain conserved Stat3 binding sites in 
their promoters while Tcf4 contains one conserved Stat3 binding site.  However, Stat3C 
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did not induce reporter expression from the 5 kb Tcf4 promoter in the luciferase reporter 
assay (Supplemental Fig. S6). 
 To determine whether endogenous Stat3 directly binds to the Tcf3 promoter in 
vivo, we used antibodies against Stat3 to perform chromatin immunoprecipitation (ChIP) 
on chromatin lysates from hair follicle cells.  We detected endogenous Stat3 bound to 
the Tcf3 promoter in regions containing conserved Stat3 binding sites (*p<0.05), but not 
in control regions that lack Stat3 binding sites (Fig. 3I).  These results suggest that Stat3 
directly binds and activates the Tcf3 promoter. 
 Although Stat3 activates the Tcf3 promoter in vitro and binds to the endogenous 
Tcf3 promoter in vivo, overexpression of constitutively activated Stat3 (Stat3C) in the 
epidermis was not sufficient to induce expression of Tcf3 (Supplemental Fig. S7A, S7B).  
Furthermore, ablation of Stat3 in the skin does not alter the expression pattern of Tcf3 
during normal development and homeostasis, as Tcf3 is expressed at similar levels in 
Stat3-deficient skin compared to wild-type skin (Supplemental Fig. S7C, S7D).  Thus, 
although it is required for upregulation of Tcf3 in response to wounding, Stat3 activation 
alone is insufficient to activate Tcf3 expression. 
 
Tcf3 overexpression rescues defective migration in Stat3-deficient cells 
Previous reports have shown that ablation of epidermal Stat3 impairs cutaneous wound 
repair in vivo and cell migration in vitro2.  Given our observations that Stat3 upregulates 
expression of Tcf3 at the skin wound edge and that Tcf3 promotes cell migration, the 
promotion of cell migration by Stat3 might be dependent on its induction of Tcf3.  To 
address this, we next determined whether Tcf3 overexpression could rescue the cell 
migration defect caused by deficiency of Stat3.  We cultured primary keratinocytes from 
Stat3fl/fl;K14-Cre (Stat3 cKO) mice28, transduced them with GFP-tagged lentiviral vectors 
expressing tet-inducible Tcf3, and enriched them by fluorescent cell sorting.  We then 
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treated the cells with Dox to induce expression of Tcf3 just prior to the migration assay. 
As expected, Stat3 cKO keratinocytes showed impaired cell migration (**p<0.001).  
Importantly, this defect was reversed by Tcf3 overexpression (**p<0.001) (Fig. 4A, B).  
The observation that forced expression of Tcf3 can rescue defective migration in Stat3-
deficient keratinocytes strongly suggests that Tcf3 is a key downstream effector of Stat3 
in this process.  
 
Tcf3 promotes cell migration non-cell-autonomously and independently of β-
catenin 
In light of the important role of Tcf3 in cell migration and wound healing, we sought to 
identify the mechanism by which Tcf3 affect this process.  Since Tcf3 can function as 
both a β-catenin-dependent transcriptional activator and a β-catenin-independent 
repressor, we first tested which of these functions is necessary in cell migration.  We 
transduced keratinocytes with GFP-tagged, tet-inducible lentiviral vectors carrying either 
myc-tagged wild-type Tcf3 or one of two Tcf3 deletion mutants: Tcf3ΔN, which does not 
bind to β-catenin and therefore cannot activate Wnt target genes; and Tcf3ΔG, which 
cannot bind Groucho/TLE-family corepressors and thus loses repressor function20.  After 
enrichment by fluorescent cell sorting, the transduced cells were treated with Dox to 
induce the expression of wild-type or mutant Tcf3 (Fig. 5A; Supplemental Fig. S8A), and 
then subjected to the in vitro wounding assay. We found that overexpressing Tcf3ΔN 
promoted cell migration to a similar extent as wild-type Tcf3 (**p<0.001), while 
overexpressing Tcf3ΔG produced no significant effect on migration (Fig. 5B, C).  The 
observation that Tcf3’s pro-migratory effect requires its Groucho-interacting domain, but 
not its β-catenin-interacting domain, suggests that Tcf3 promotes cell migration by 
interacting with Groucho/TLE family members as a corepressor.   
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 We next determined whether Tcf3 promotes cell migration cell-autonomously or by 
paracrine effects on neighboring cells.  We cultured tet-inducible Tcf3 keratinocytes 
(K14-rtTA;TRE-mycTcf3) or single-transgenic controls (K14-rtTA) in the presence or 
absence of Dox and collected their conditioned media (CM).  We then tested the ability 
of the CM to influence migration of wild-type keratinocytes.  Cells that were incubated 
with CM from Tcf3-overexpressing cells displayed enhanced migration compared with 
cells incubated with control CM (**p<0.001).  This suggests that Tcf3-induced cells 
produce secreted factors that affect the migration of wild type cells (Fig. 5D, E) and 
implies that Tcf3 promotes cell migration non-cell-autonomously. 
 Moreover, we found that CM from Tcf3ΔN-, but not Tcf3ΔG-overexpressing cells 
promoted cell migration (**p<00.1), confirming that indeed Tcf3 promotes cell migration 
independently of β-catenin and non-cell autonomously (Supplemental Fig. S8B). 
 Since Tcf3 promotes cell migration non-cell autonomously, we wanted to determine 
whether Tcf3 also non-cell autonomously promotes wound healing.  After creating full 
thickness wounds of 1cm2 on the dorsal skin of wild-type mice, we applied CM from 
Tcf3-overexpressing cells (Tcf3-CM) or control cells onto the wound sites (n=5 each 
group).  We found that daily application of Tcf3-CM onto the wound sites significantly 
accelerated wound closure  (*p<0.05) (Fig. 6A, B). 
 
Lipocalin 2 is the critical key secreted mediator of Tcf3-induced wound healing 
Since Tcf3 promotes cell migration and wound healing in a non-cell autonomous 
manner, we sought to identify the secreted factors involved in this process.  We 
searched previously compiled microarray data for genes encoding extracellular proteins 
that were upregulated upon Tcf3 overexpression22.  Of the potential candidates, we 
verified that lipocalin 2 (Lcn2) expression is increased in response to Tcf3 
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overexpression in both cultured keratinocytes (Fig. 6C and Supplemental Fig. S9A,B) 
and in vivo in skin (Supplemental Fig. S9C).  We also found that Lcn2 expression is 
induced at the wound edge (Supplemental Fig. S9D). 
 Lcn2 (also known as NGAL, 24p3, uterocalin, or siderocalin) is an acute-phase 
protein expressed in certain tissues in response to injury and inflammation30.  It is also 
overexpressed in many types of cancer and is implicated in metastasis in breast 
cancer31-33.  Moreover, it is involved in promoting cell motility in both neurons and cancer 
cells33-36.  To determine whether Tcf3 promotes cell migration and wound healing 
through upregulation of Lcn2, we incubated the CM collected from Tcf3 overexpressing 
cells (Tcf3-CM) with antibodies against Lcn2 and evaluated how the inhibition of Lcn2 
affects cell migration and wound healing.  We found that immunodepletion of Lcn2 from 
Tcf3-CM reversed the pro-migratory effect in vitro (**p<0.001) (Fig. 6D) and its pro- 
wound closure effect in vivo (*p<0.05) (Fig. 6E and Supplemental Fig. S10).  A similar 
loss of efficacy was observed following Lcn2 immunodepletion in the ex vivo explant 
culture system (*p<0.05) (Supplemental Fig. S11).  Together these results suggest that 
Tcf3 promotes cell migration and wound healing through upregulation of the secreted 
factor Lcn2.  Since our data suggest that the pro-migratory effects of Tcf3 are dependent 
on its transcriptional repressor function, the induction of Lcn2 due to Tcf3 
overexpression is most likely to be an indirect effect. 
 To determine whether Lcn2 alone is sufficient to promote epidermal cell migration, 
we tested the effect of CM collected from Lcn2-overexpressing cells (Lcn2-CM) on cell 
migration.  We found that keratinocytes that were incubated in Lcn2-CM migrated more 
than keratinocytes incubated with control CM (**p<0.001) (Fig. 6F).  To determine 
whether Lcn2 itself can promote wound healing in vivo, we topically applied Lcn2-CM 
onto full-thickness wounds and evaluated its effect on the wound repair process.  We 
found that the application of Lcn2-CM (n=4) accelerated wound closure significantly 
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(*p<0.05) more than the application of control CM (n=4) (Fig. 6G, H).  Similarly, the 
application of recombinant Lcn2 protein onto wounds also substantially accelerated 
wound closure (*p<0.05) (Supplemental Fig. S12).  Since overexpression of Lcn2 does 
not promote proliferation in vitro (Supplemental Fig. S9E), these data suggest that Lcn2 
promotes wound healing by promoting cell migration. 
 To determine whether Lcn2 is essential in the wound repair process, we 
immunodepleted Lcn2 by topically applying anti-Lcn2 (n=8) or isotype control antibodies 
(n=8) onto full-thickness wounds in nude mice.  Wounds that were treated with Lcn2 
blocking antibodies repaired less efficiently than the wounds that were treated with IgG 
control (*p<0.05) (Fig. 7A, B).  These data strongly suggest that Lcn2 is required for 
wound repair. 
 
Exogenous Lcn2 rescues defective cell migration and wound healing in Stat3-
deficient skin  
Since Tcf3 overexpression can rescue defective cell migration in Stat3-deficient 
keratinocytes and Lcn2 is the key mediator of the Tcf3-induced promigratory effect, we 
sought to determine whether inhibition of Lcn2 could compromise the Tcf3-mediated 
rescue of Stat3-deficient keratinocytes.  We first transduced primary keratinocytes from 
Stat3fl/fl;K14-Cre (Stat3 cKO) mice with a GFP-tagged lentiviral vector expressing tet-
inducible Tcf3 or an empty vector control.   After enriching them by fluorescent cell 
sorting, we then treated the cells with Dox to induce expression of Tcf3 prior to the 
migration assay.  At the start of the migration assay we added Lcn2 blocking antibodies 
or isotype control antibodies to the keratinocytes and then quantified the migrated 
distance after 48hrs.  As in our previous experiments, Stat3-deficient keratinocytes 
migrated less than the control (K14-cre;Stat3+/fl) keratinocytes and overexpression of 
Tcf3 reversed this migration defect.  However, when Lcn2 was depleted, overexpression 
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of Tcf3 could no longer rescue the defective migration in Stat3-deficient keratinocytes 
(**p<0.001) (Fig. 7C, Supplemental Fig. S13).  
We next examined whether Lcn2 expression could rescue the defective wound repair 
process in Stat3-deficient skin.  We created full-thickness wounds on Stat3 cKO (n=11) 
or control mice (n=13) and applied recombinant Lcn2 protein or vehicle control onto the 
wound beds.  As expected, Stat3 cKO skin showed defective wound repair (**p<0.001).  
Importantly, the application of recombinant Lcn2 rescued the defective wound healing in 
Stat3 cKO skin (*p<0.05) (Fig. 7D, E).  These data suggest that Stat3’s role in cell 
migration and wound healing is mediated by Lcn2 via Tcf3. 
 
DISCUSSION 
To understand and enhance the wound repair process, it is essential to understand the 
molecular mechanisms underlying the steps contributing to wound repair. Stat3 is one of 
the few known transcription factors that have been implicated in cell migration and re-
epithelialization during wound repair.  Conditional ablation of Stat3 in the mammalian 
epidermis impairs cutaneous wound healing in vivo and epidermal cell migration in vitro2.  
Stat3 deficiency causes cell migration defects during gastrulation in zebrafish27.  Mice 
carrying null alleles of Stat3 also die during early gastrulation37, suggesting that Stat3 
plays a similar role in cell migration during mouse development.  In addition, aberrant 
Stat3 activity promotes tumor invasion and metastasis in various cancers38-42.  Despite 
the evident role of Stat3 in cell migration, the downstream genes targeted by Stat3 to 
regulate cell migration are still largely unknown. 
 Our demonstration that Stat3 directly upregulates Tcf3 expression during wounding 
and that Stat3 can directly activate Tcf3 transcription provides the first direct link 
between the Stat3 and Tcf3 transcriptional networks, both of which are crucial for tissue 
homeostasis.  More importantly, we show that Tcf3 itself promotes cell migration and 
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that its forced expression rescues defective cell migration in Stat3-deficient cells.  Our 
data not only uncover a novel role for Tcf3 in cell migration, they also suggest that Stat3 
promotes cell migration through its upregulation of Tcf3. 
  Moreover, our findings that Tcf3 is induced in response to wounding and directly 
promotes wound healing demonstrate a crucial role for transcriptional regulation of 
Lef/Tcf factors in determining functional outcomes.  This is in contrast with the traditional 
model in which Tcf activity is primarily regulated by the presence or absence of nuclear 
β-catenin.  In addition, our finding that Tcf3 can promote cell migration without its β-
catenin-interacting domain presents a novel β-catenin-independent role for Tcf3 and 
underlines the importance of Tcf3’s ability to act as a transcriptional repressor.   
 It is interesting to note that overexpression a ΔNLef, a truncated Lef1 that lacks a 
β-catenin binding site, in the skin results in a delay of wound closure43.  Because ΔNLef 
inhibits β-catenin signaling, it is thought that impaired Wnt signaling maybe the cause of 
the delay in wound healing.  However, inhibition of Wnt signaling by overexpression of 
the Wnt inhibitor Dkk1 does not alter wound closure, instead affecting only hair follicle 
neogenesis44.  This suggests that Wnt signaling is not crucial for the reepithelialization 
process.  Consistent with the nonessential role of Wnt in epidermal wound repair, 
overexpression of Wnt (Wnt7a) does not affect wound closure44.  It is therefore tempting 
to speculate that ΔNLef delays wound closure by a negative effect on Tcf3, possibly 
though direct competition with Tcf3 for target gene binding. 
 Finally, our novel observation that Tcf3 acts non-cell-autonomously via Lcn2 to 
promote migration and wound healing offers a new mechanism by which Tcf3 acts to 
shape the tissue microenvironment during wounding.  We have shown that topical 
application of CM collected from Tcf3-overexpressing cells or Lcn2-overexpressing cells 
both enhance wound healing in mice.  Blockade of Lcn2 impairs wound healing and 
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diminishes Tcf3-CM’s ability to affect cell migration, suggesting that the secretion of 
Lcn2 is both necessary and sufficient to promote cell migration and wound healing in 
response to Tcf3.   
 Lcn2 is an acute phase protein, upregulated at sites of inflammation and 
injury30,34,45.  It is an established biomarker for renal injury, and its levels are increased in 
serum of patients with psoriasis46,47.  It is also expressed at a high level in a variety of 
tumors48-51.  Lcn2’s diverse roles range from being a bacteriostatic agent to a promoter 
of cell motility52,53.  Lcn2’s role in cell migration has been shown in several model 
systems.  Ablation of Lcn2 results in impaired migration of astrocytes to injury sites in 
both mice and zebrafish36,54.  Overexpression of Lcn2 in vitro increases cell motility and 
invasiveness of breast cancer cells33,34.  Although Lcn2 can promote cell motility, the 
molecular mechanism underlying this function is not known. Overexpression of Lcn2 
downregulates expression of E-cadherin and increases expression of mesenchymal 
markers, while downregulation of Lcn2 inhibits cell migration and the mesenchymal 
phenotype34.   Based on this finding, it is conceivable that Lcn2 promotes cell migration 
by affecting cell adhesion via its downregulation of E-cadherin.  However, how Lcn2 
brings about the downregulation of E-cadherin is still unknown.  
 Furthermore, since Lcn2 binds to and stabilizes matrix metalloproteinase-9 
(MMP9) 55, a proteinase that is important for cell migration and wound healing, it is also 
possible that Lcn2 promotes cell migration by increasing the activity of MMP-9.  MMP-9 
belongs to the MMP family of zinc-dependent endopeptidases that degrade components 
of the extracellular matrix, allowing cell migration to occur56.  Mice with MMP-9 
deficiency show delayed cell migration and wound repair57. 
 Although it remains to be elucidated how Lcn2 promotes cell migration, our findings 
clearly demonstrate that Lcn2 has a crucial role in promoting epidermal cell migration 
and wound healing in skin.  We show that the application of Lcn2 to the wound sites 
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substantially accelerates wound healing while the application of antibodies against Lcn2 
significantly delays wound healing.  Importantly, the application of Lcn2 rescues 
defective wound healing in Stat3-deficient skin, suggesting that Stat3 acts through Tcf3’s 
downstream effector Lcn2. 
 Although our data clearly show that Tcf3 overexpression induces the expression of 
Lcn2 and promotes cell migration and wound healing, we still do not know how Tcf3 
brings about the induction of Lcn2.    Tcf3’s promotion of cell migration is dependent on 
its interaction with the transcriptional repressor Groucho and not with the activator β-
catenin, suggesting that Tcf3 acts as a repressor in its role in cell migration.  Hence, it is 
likely that Tcf3 represses repressor(s) of Lcn2 expression, which consequently leads to 
the induction of Lcn2.  We are currently seeking to identify the regulator(s) of Lcn2 that 
Tcf3 affects that impact cell migration and wound healing. 
 In conclusion, we identify a novel role for Tcf3 and Lcn2 in epidermal cell migration 
and skin wound repair.  Lcn2 is already implicated in innate immune response to 
bacterial invasion and cell motility in neurons and cancer cells33-36,52,53.  Our findings 
identify a new role for Lcn2 in epidermal cell migration and skin wound healing and also 
provide a potential target for development of new treatments for defective wound repair. 
 
METHODS 
 
Mice  
Tet-inducible Tcf3 mice were generated by crossing K14-rtTA with TRE-Tcf3 22. 
Intercrosses between the Stat3fl/fl line28 and K14-Cre (Jackson Laboratory) were done to 
yield Stat3 cKO mice.  Intercrosses between the Tcf3fl/fl line23 and K14-Cre yielded Tcf3 
cKO mice. 
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Tet-inducible Stat3C transgenic mice were generated by crossing K14-rtTA with TRE-
Stat3C. The XhoI and DrdI fragment of pTRE-Stat3C was microinjected into pronuclei of  
FVB/N embryos to generate the TRE-Stat3C transgenic line. 
 
In vivo wound closure assay 
For wounding experiments, 8- to 10-week-old Stat3 cKO (Stat3fl/fl;K14-Cre) or control 
(Stat3fl/f) mice were anesthetized with intraperitoneal administration of ketamine/xylazine 
and full-thickness wounds were made on the mid dorsal skin with 4-mm disposable 
biopsy punches.  Skins were harvested and embedded in OCT (Tissue-Tek) 3, 5, or 7 
days post wounding.   
To evaluate the effect of Tcf3 expression on wounds repair, full thickness wounds of 1 
cm2 were created on the dorsal skins of Tcf3 inducible (K14-rtTA;TRE-mycTcf3) or 
control (K14-rtTA or TRE-mycTcf3) mice which had been maintained on doxycycline 
(200mg/kg) containing chow (Bio-Serv) for 6 months starting at 8 weeks of age.   Skins 
were harvested and embedded in OCT 6 or 10 days post-wounding.   
To evaluate the effect of conditioned media (CM) from Tcf3- or Lcn2-overexpressing 
cells on wound closure, full thickness wounds of 1cm2 were created on the dorsal skins 
of 8-10 week old ICR mice.  200 µl of CM was topically applied onto the wound sites and 
the surface areas of the wounds were measured. Each wound was covered with 
Tegaderm film and a self-adherent wrap (Coban) to prevent leakage, desiccation and 
infection.  
CM was generated by feeding 80~90% confluent keratinocytes in 15-cm tissue culture 
plates with 18 ml/plate serum-free MCDB153 medium and incubating for 48 h. The CM 
was concentrated 10-fold by using Amicon centrifugal filter units with a 10-kDa cut-off 
(Millipore) following the manufacturer’s instructions. The concentrated CM was mixed 
with carboxymethylcellulose solution (final concentration, 3% w/v) before being topically 
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applied onto the wound bed.  To evaluate the effect of recombinant Lcn2 on wound 
closure, 200µl of Lcn2 (R&D Systems), dissolved at 1µg/ml in PBS + 3% 
carboxymethylcellulose was applied onto the wound bed and wound closure was 
evaluated as described above.  To evaluate the depletion of Lcn2 on wound healing, 
200µl of 3µg/ml anti-Lcn2 (R&D Systems) or goat IgG in PBS+3% 
carboxymethylcellulose were applied every other day for 11 days to 1cm2 wounds that 
were created on nude mice.  To evaluate whether recombinant Lcn2 can rescue 
defective wounding healing in Stat3 cKO mice, 1cm2 wounds were created on dorsal 
skins of Stat3 cKO or littermate controls that were waxed for 2 weeks prior to wounding.  
200µl of 2µg/ml EGF (Invitrogen) with or without recombinant 2µg/ml of Lcn2 in PBS 
+3% carboxymethylcellulose were applied to the wound beds every other for 11 days.  
Wound closure was evaluated as described above. 
All mice were maintained in the AALAC-accredited animal facility at Baylor College of 
Medicine and were used according to protocols that were approved by the Baylor 
College of Medicine institutional care and use committee. 
 
Ex vivo skin explant outgrowth assay 
Ex vivo explant culture of 2~4 d old mouse skin was carried out as previously 
described58,59. Circular skin biopsies were obtained from dorsal skin of 2-d-old mice 
using 4-mm punches (Sklar) and plated with 0.3-ml medium in 24-well plates (BD 
Biosciences).  After overnight incubation at 37°C, 7.5% CO2, explants were submerged 
in media with or without Dox (1 µg/ml) and grown for another 8 d before fixing (4% PFA 
for 10 min; 100% methanol for 10 min at -20°C). Medium was changed every 2–3 d.  In 
cases of Mitomycin C treatment, skin explants were treated with 8 µg/ml Mitomycin C 
(Roche) 48 h post Dox treatment.  After Mitomycin C treatment, cultures were washed 
three times with PBS and refed with fresh media. Keratinocytes in the cellular outgrowth 
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of explants were identified by immunostaining for Keratin 17 and by morphological 
appearance.  Images of the cellular outgrowth from each explant were taken, and the 
proximal distance extending between the explant biopsy and the distal edge of the 
cellular migration was measured using NIH ImageJ software (http://rsb.info.nih.gov/ij/).  
Measuring the surface area covered by the keratin 17-positive outgrowth yielded similar 
findings. 
 
Plasmid constructs 
Gateway entry vectors for the Lef/Tcf genes of interest were generated as follows: The 
myc-tagged Tcf3 wild-type and mutant alleles20 were PCR-amplified from their 
respective vectors with the addition of EcoRI and XhoI sites with primers 
myctag_EcoRI_fw and Tcf3∆C_XhoI_rv2 (for Tcf3∆C) or Tcf3_XhoI_rv (for the others). 
The PCR was conducted using Phusion DNA polymerase (New England Biolabs, 
Ipswich, MA). The resulting PCR products were then subcloned into pENTR 1A (Life 
Technologies, Carlsbad, CA). Myc-tagged Tcf4 was subcloned from K14-mycmTcf423  
into pENTR 1A by BamHI/NotI digest. Myc-tagged Lef1 was subcloned from K14-
mycmLef160 into pENTR 1A by EcoRI/XbaI digest. To clone myc-tagged Tcf1, total RNA 
was TRIzol-purified from adult C57BL/6 mouse splenocytes and reverse-transcribed into 
cDNA using SuperScript III reverse transcriptase (Life Technologies, Carlsbad, CA) with 
oligo(dT)20 primers. The full-length Tcf1 ORF (from NM_009331) was PCR-amplified, 
with the addition of EcoRI and NotI sites and a myc tag, using the primers 
mTcf1_myc_Eco_fw and mTcf1_Not_rv. The PCR was conducted using Herculase II 
polymerase (Agilent Technologies, Santa Clara, CA). The resulting PCR product was 
digested and subcloned directly into EcoRI/NotI-digested pENTR 1A. A negative-control 
entry vector was generated by digesting pENTR 1A with EcoRI (to release the ccdB 
suicide gene) and recircularizing it. To generate Tet-inducible lentivirus constructs, the 
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Gateway entry vectors were recombined into pINDUCER2125 using LR Clonase II (Life 
Technologies, Carlsbad, CA) according to the manufacturer’s instructions. 
Tcf3pro-luc constructs were generated by PCR from mouse embryonic stem cell 
genomic DNA. 4884bp of the proximal Tcf3 promoter was amplified with primers to 
introduce an MluI site at the 5’ end and an XhoI site at the 3’ end. The fragment was 
then subcloned into the pGL3-basic vector (Promega). Site-directed point mutation of 
Tcf3 promoter for Stat3 binding sites was made as described61. 
pTRE-Stat3C was engineered as follows:  the β-globin intron was subcloned from the 
K14 cassette vector (Elaine Fuchs lab) into the SacII site of pTRE2 (Clontech)  to form 
the vector pTRE2I.  The Stat3C-Flag ORF from the pBabe-Stat3C expression vector (a 
gift from Dr. Jacqueline Bromberg of Memorial Sloan-Kettering Cancer Institute) was 
digested with BamHI, then ligated into the BamHI site of pTRE2I. 
All plasmids were verified by restriction digest and sequencing before use.  All cloning 
primers are listed in Supplementary Table 1. 
 
Lentivirus production  
293T cells were cultured in IMDM containing 10% FBS, 2 mM supplemental L-glutamine, 
and pen/strep. To produce lentivirus particles, cells were plated at 4 x 106 cells per 10 
cm plate. The following morning, they were transfected with 7 µg pINDUCER vector and 
750 ng each of pHDM-Hgpm2, pRc/CMV-RaII, pHDM-tat1b, and pHDM-VSV-G with 30 
µL of TransIT-293 transfection reagent (Mirus Bio) per 10 cm plate. 24 hours after 
transfection, media was changed and volume reduced to 6 mL per 10 cm plate. Virus-
containing supernatants were collected at 48 and 72 hours post-transfection, pooled, 
and concentrated by ultracentrifugation at 85,000 x g for two hours. Virus particles were 
resuspended in a small amount of keratinocyte growth media, separated into aliquots, 
and stored at -80°C until use. Virus preps were titered by infection of 293T cells with 10-
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fold serial dilutions of lentivirus followed by flow cytometric analysis for GFP positivity. 
Titers (in transduction units per microliter) were calculated using the formula [(fraction 
GFP positive)(number of cells at time of infection)] / [(dilution factor)(volume of viral 
inoculum)]. 
Keratinocyte culturing and lentiviral infection 
Primary keratinocytes were isolated as described22. Primary keratinocytes were cultured 
on J2 fibroblasts treated with Mitomycin C (Roche) for 3 passages before being cultured 
without feeder cells.  
For lentiviral infections, keratinocytes were plated at 1 x 105 cells per well in 6-well tissue 
culture plates. The following day, one or two representative wells were trypsinized and 
counted. Lentivirus preps were thawed and diluted in keratinocyte growth media 
containing 8 µg/mL Polybrene (Sigma-Aldrich, St. Louis, MO), to a final multiplicity of 5 
transduction units per cell. Growth media was aspirated from the plated keratinocytes 
and replaced with diluted lentivirus (1 mL/well). The plates were incubated at 37°C for 15 
minutes and then centrifuged at 1100 x g, 32°C, for 30 minutes. After centrifuging, the 
cells were washed with 3 mL/well PBS, refed with keratinocyte growth media, and 
returned to 37°C for growth. GFP expression was detectable 72 hours following 
infection. 
For the cell proliferation assay, 2 x 104 cells were plated onto each well of a 24 well 
plate.  Cells were trypsinized and counted in triplicates using a Beckman Z2 Coulter 
counter every 24 hours. 
 
Flow Cytometry 
After lentiviral transduction, cells were grown to confluence, and then sorted by flow 
cytometry. Cells were trypsinized, then resuspended in ice-cold sorting buffer (4% 
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calcium-free chelated FBS in PBS, ~200-300 µm per 10cm plate), and strained into 30 
µm strainer-cap FACS tubes and kept on ice. Cells were isolated on a FACSAria II or IIu 
cell sorter (BD Biosciences), using the 100 µm nozzle at a sheath pressure of 20 psi. 
GFP positives (typically 60-80% of cells) were collected in chilled 15 mL catch tubes 
containing 6 mL of keratinocyte growth media. After collection, cells were pelleted, 
resuspended, counted, and replated for growth in keratinocyte growth media.  
In vitro wounding assay 
The in vitro wounding assay was performed as described2,24 with some modifications.  
Keratinocytes were cultured in 6-well plates until reaching confluence. They then were 
starved in serum-free basal medium with or without doxycycline for 22 hr, followed by 
treatment with 10 µg/ml Mitomycin C for 2 hr. After creating a straight scratch with a 
pipet tip, the cells were washed three times with PBS to remove Mitomycin C and cell 
debris. For testing functions of various genes in cell migration, the cells were refed with 
serum-containing medium with or without doxycycline, and cell migration was stopped 
14~16 hrs later by fixing with 3.8% PFA.  Alternatively, in the rescue experiments, 
following starvation, Mitomycin C treatment and scratching, the cells were incubated in 
basal medium complemented with 10 ng/ml mouse recombinant EGF (Invitrogen, United 
States) with or without doxycycline.  Immediately after a scratch was created, markings 
were made adjacent to the scratch as a reference for camera positioning. Photographs 
were taken at the initial and final time points using a phase-contrast microscope 
(Axiovert 40; Zeiss, Germany).  By comparing the images from initial to final timepoints, 
the area filled by migrating cells was quantified with ImageJ analysis software 
(http://rsb.info.nih.gov/ij/). For each sample, over 30 non-overlapping fields were 
measured at each timepoint; and each experiment was repeated at least twice. Values 
represent the mean ± s.e.m. of migrated area beyond the edges of the scratch. 
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Luciferase reporter assay 
pBabe-Stat3 and pBabe-Stat3C expression vectors were gifts from Dr. Jacqueline 
Bromberg (Memorial Sloan-Kettering Cancer Institute).  For the reporter assay, 
keratinocytes were plated at density of 2 x 104 cells per well in a 24-well plate one day 
before transfection.  The Tcf3pro-luc, Tcf4pro-luc and the Stat3 expression vector, along 
with the control vector pRL-TK were transfected using FuGENE 6 (Roche) according to 
the manufacturer’s instructions. Luciferase reporter activity was measured using the 
Dual-Luciferase Reporter system 48 hours after transfection (Promega) with Firefly 
luciferase values normalized to Renilla luciferase values. 
Real-time PCR 
Total RNA was purified with the ZR RNA Miniprep kit (Zymo Research, Irvine, CA) and 
1ug of each RNA sample was reverse transcribed with the Superscript III First-Strand 
Synthesis System (Life Technologies, Carlsbad, CA) using Oligo(dT) primers. PCR 
amplifications of genes of interest were performed using primers located in different 
exons or spanning intron-exon junctions to obtain amplicons less than 150 bp in length. 
Real-time PCR was performed with LightCycler DNA Master SYBR Green I reagents on 
a LightCycler 480 real-time PCR system (Roche, United States). Differences between 
samples and controls were calculated based on the 2-ΔΔCP method, using the Mrpl19 gene 
as an internal control.  Primer sequences are listed in Supplemental Table 1. 
Immunohistochemistry and immunofluorescence  
For immunohistochemical detection, 5 µm paraffin sections were used; and endogenous 
biotin and peroxidase activity were blocked.  The color was developed with DAB 
chromogen (ImmPACT DAB; VectorLabs, United States) and the sections were 
counterstained with hematoxylin.  
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Immunofluorescence analysis was performed as described22.  6~8 µm frozen backskin 
sections were fixed in 4% PFA. For blocking, the MOM kit (Vector Laboratories, 
Burlingame, CA) was used for mouse monoclonal antibodies, and the following blocking 
buffer for all other antibodies: 10% normal donkey serum, 2% BSA, 2% fish skin gelatin, 
2% Triton X-100 in PBS.  Primary antibodies were used at the following concentration: 
guinea pig anti-Tcf3 (1:200, lab-generated), goat anti-Tcf4 (1:100; Santa Cruz), rabbit 
anti-Tcf1 (1:50; Cell Signaling), rabbit anti-Lef1 (1:150; Cell Signaling), mouse anti-myc 
tag (1:500; Zymed), mouse anti-β-catenin (Sigma), mouse anti-Stat3 (1:300; Cell 
Signaling), pY705-Stat3 (1:100; Cell Signaling), rat anti-cd104 (1:200; BD Biosciences) 
goat anti-Lcn2 (1:150;R&D Systems).  Antigens were visualized with FITC- or RRX-
conjugated secondary Abs (Jackson Labs).  All images were acquired with Zeiss 
Axioskop microscope.  
Immunoblot and in situ hybridization 
To analyze tet-inducible gene expression, 40 µg protein from the total cell lysate of 
lentivirus-transduced keratinocytes was resolved by SDS-PAGE.  The separated 
proteins were then immunoblotted, probed with primary myc tag antibody (1:3000, 
Abcam), and detected by chemiluminescence (SuperSignal West Pico, Thermo 
Scientific). 
The in situ hybridization was carried out as described previously62.  5-day post wounding 
back skins of 8-10 week-old wild-type and Stat3 cKO mice were frozen side by side in 
Tissue-Tek OCT reagent, and cryo-sections (16 µm) were prepared. The sections were 
fixed in 4% formaldehyde in PBS and acetylated, followed by pre-hybridization. Probes 
used were DIG-labeled (Roche) sense and anti-sense transcripts of mouse cDNAs 
of Tcf3 (NM_001079822, nucleotides 1-1030).  After hybridization, sections were treated 
with RNase A and extensively washed. The DIG-label was detected by an anti-DIG Fab 
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(Roche) coupled to alkaline phosphatase using NBT/BCIP (Roche) according to the 
manufacturer's instructions. Sections were then counterstained with nuclear fast red 
(Vector Laboratories). 
Chromatin immunoprecipitation 
In vivo chromatin immunoprecipitation (ChIP) was performed according to a modification 
of a protocol from Upstate Biotechnology.  Hair follicle cells were isolated from P4 
mouse pups as described62 and were treated with 1.42% formaldehyde in 4% FBS-PBS 
solution at room temperature for 15 min.  Cross-linked DNA was sonicated to form 
fragments ranging from 200 to 500 bp in length. After preclearing, ChIP lysates were 
immunoprecipitated with rabbit anti-Stat3 (Cell Signaling), and rabbit IgG (Jackson 
Laboratory). Pulled-down DNA fragments were recovered with the Chelex-100-mediated 
purification method63.  Conserved Stat3 sites identified by rVista analysis of 5# upstream 
sequences were defined by the ECR Browser and Ensembl software. Stat3 sites were 
chosen for ChIP analysis based on the conservation and alignment between mouse, rat 
and human. qPCR was done with the LightCycler 480 system (Roche, United States) 
using the PerfeCTa SYBR Green FastMix kit (Quanta Biosci) and primers to produce 
amplicons less than 150 bp.  Primer sequences are listed in Supplemental Table 1.  
  
Statistical Analysis!
Statistical analyses were performed using Microsoft Excel. The Student’s t-Test function 
with a two-tailed distribution was used to calculate p values. Differences were regarded 
as statistically significant and as statistically highly significant if p values were <0.05, and 
p < 0.001, respectively. 
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FIGURE LEGENDS 
 
Figure 1. Tcf3 is induced at the wound edge and its overexpression promotes cell 
migration.  
(A) Images of immunofluorescence analysis of wounded and unwounded skins of WT 
and Tcf3 cKO skins show Tcf3 is induced at the wound edge of WT and not Tcf3 cKO 
skins.  Full thickness wounds were created on dorsal skins of 10-week old mice and 
isolated 5 days post wounding.  Skins were analyzed by immunofluorescence with 
antibodies against Tcf3 (green) and keratin 5 (red).  Wound-distant skin samples from 
the same mice were used as unwounded controls.  Bar denotes 20µm. 
(B) Images of keratinocytes 16hrs after the initiation of migration assay showing Tcf3-
induced cells migrate more than control cells. Primary keratinocytes were isolated from 
tet-inducible Tcf3 (K14rtTA;TRE-Tcf3) or control (K14-rtTA) mice, grown to confluence, 
treated with doxycycline (Dox) or vehicle 24hrs prior to being subjected to the migration 
assay.   Cells were treated with Mitomycin C for 2 hours to arrest proliferation, and a 
scratch was then made in the confluent monolayer using a pipet tip.  The size of the 
scratch was measured at the beginning of the experiment and the area of cell migration 
was quantified after 16hrs using ImageJ software.  Black bar denotes 200µM.  
(C) Tcf3-induced cells show a 60% increase in migration compared with controls.  Graph 
quantifying the area migrated by cells treated with Dox relative to the area migrated by 
cells treated with vehicle control. For each sample, over 30 non-overlapping fields were 
measured at each timepoint; and each experiment was repeated twice. Data are the 
mean ± s.e.m. **p<0.001. 
 (D) Tcf3 overexpression promotes cell migration in ex vivo skin explant culture.  Graph 
quantifying the distance of outgrowth (µm) of epithelial cells from skin explants from 
control (K14-rtTA) or tet-inducible Tcf3 mice (K14-rtTA;TRE-Tcf3) that were treated with 
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vehicle or Dox at day 8 after plating.  4-mm dorsal skin punches were cultured for 8 days 
in the presence or absence of Dox and proliferation was blocked by Mitomycin C 
treatment on day 3.  Explants from a minimum of 4 mice were analyzed for each 
condition. 
(E) Representative images of epithelial outgrowth from explants that were 
immunostained with keratin 17 antibody and counterstained with hematoxylin after 8 
days in culture.  Bar denotes 1mm. 
  
Figure 2.  Tcf3 overexpression promotes wound healing. 
(A) Images of skin wound sites taken 6 and 10 days post wounding.  An area of 1cm2 
full-thickness wounds were created on dorsal skins of tet-inducible Tcf3 (K14-rtTA;TRE-
mycTcf3) or control (K14-rtTA or TRE-mycTcf3) mice that had been maintained on a 
doxycycline containing diet (n=5).  6 and 10 days after wounding, images of the wound 
sites were taken and the skins were embedded in OCT for analysis.  The areas of the 
wounds are smaller in Tcf3-induced skins, indicating that Tcf3 expression accelerated 
wound repair. 
(B) Graph quantifying the average area of the wounds 6 and 10 days post wounding 
show that wound closure was accelerated in Tcf3-induced skins.  Areas of the wounds 
were measured with ImageJ software.  Data are mean s.e.m. *p<0.05. 
(C) H&E images of wounded skins from Tcf3-induced and control mice show faster re-
epithelialization in the Tcf3-induced skin.   Images of skins containing the wound sites 
were taken and merged using Panorama software.  Open triangle indicates the edge of 
the reepithelialization sites.  Black bar denotes 1mm. 
(D) Graph quantifying the average width of the unrepaired wound sites based on H&E 
images.  Data are mean s.e.m. *p<0.05. 
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Figure 3. Tcf3 induction in response to wounding is dependent on Stat3. 
(A-B) Tcf3 and activated Stat3 (phospho-Y705) are induced at the wound edge in skin. 
Full-thickness wounds were created on dorsal skins of 10-week old mice and isolated 5 
days post wounding.  Skins containing the wound sites were analyzed by 
immunofluorescence with antibodies against phospho-Y705-Stat3 (red) and Tcf3 
(Green). Unwounded skins from the same mice were used as controls.  
(C-D) Ablation of Stat3 abolishes Tcf3 induction at the wound edge.  Images of 
immunofluorescence analysis of the wound edge of skin from Stat3fl/fl;K14-Cre (Stat3 
cKO) mice.  Unwounded skins from the same mice were used as controls.   
(E-F) Tcf3 mRNA is induced at the skin wound edge and its induction requires Stat3 
expression. In situ hybridization analysis of Tcf3 expression at the wound edge of wild-
type and Stat3 ckO skin using antisense to Tcf3 as probe (e) compared with Tcf3 sense 
as a control (f).  Bar denotes 50µm. 
 (G) Constitutively activated Stat3 activates the Tcf3 promoter.  Keratinocytes were 
transfected with Tcf3 promoter-Firefly luciferase and Renilla luciferase constructs, 
together with constructs expressing either Stat3, constitutively active Stat3 (Stat3C) or 
control vector.  Luciferase activity was measured and Firefly luciferase activity was 
normalized over Renilla luciferase activity.  Graph shows normalized luciferase activity 
relative to vector control.  Experiments were repeated three times. Data are mean ± 
s.e.m.  *p<0.05. 
(H) Constitutively activated Stat3 activates the native Tcf3 promoter but not a Tcf3 
promoter lacking conserved Stat3 binding sites.  Keratinocytes were transfected with 
wild-type or mutated Tcf3 promoter-Firefly luciferase and Renilla luciferase constructs, 
together with constructs expressing Stat3C or empty vector.  Graph shows normalized 
luciferase activity relative to vector control.  Experiments were repeated three times.  
Data are mean ± s.e.m.  *p<0.05, **p<0.01. 
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(I) Endogenous Stat3 binds to the Tcf3 promoter in epidermal cells.  Chromatin 
immunoprecipitation (ChIP) was performed with anti-Stat3 or isotype control antibodies 
on crosslinked hair follicle cell chromatin lysate.  Amount of chromatin precipitated by 
Stat3 or IgG was measured by qPCR using primers spanning regions containing Stat3 
binding sites (sites 1-3) or regions without Stat3 conserved binding sites (neg cont).  The 
graph shows the amount of fold enrichment of Stat3-immunoprecipitated DNA relative to 
IgG-immunoprecipitated DNA.  Experiments were repeated three times.  Data are mean 
± s.e.m.  *p<0.05. 
 
Figure 4.  Tcf3 induction rescues the defective migration in Stat3-deficient cells. 
(A) Stat3-deficient cells have impaired cell migration which is reversed by the 
overexpression of Tcf3. Primary keratinocytes from Stat3fl/fl (cont) or Stat3fl/fl;K14-Cre 
(Stat3 cKO) mice were isolated  and were transduced with GFP-tagged lentiviral vector 
expressing tet-inducible Tcf3 or with empty vector control.  After the transduced cells 
were enriched by fluorescent cell sorting, they were grown to confluence and then 
subjected to a migration assay with or without Dox.  Images of keratinocytes 48hrs after 
initiation of the migration assay. Black bar denotes 200µm.   
(B) Graph quantifying the relative area the cells migrated normalized over vehicle 
control.  For each sample, over 30 non-overlapping fields were measured at each 
timepoint; and each experiment was repeated three times. Data are the mean ± s.e.m. 
**p<0.001. 
 
Figure 5. Tcf3 promotes cell migration non-cell autonomously and independently 
of its role as a cofactor to β-catenin. 
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 (A) Real Time PCR analysis of level of expression of transduced tet-inducible Tcf3 and 
its mutant versions, Tcf3ΔN and Tcf3ΔG, in response to Dox. Keratinocytes were 
transduced with GFP-tagged, tet-inducible lentivectors carrying myc-tagged Tcf3 or its 
mutant versions. Transduced cells were isolated by fluorescent cell sorting and were 
treated with Dox or vehicle control for 24 hours prior to being harvested for mRNA 
analysis.  
(B) The migration-promoting effect of Tcf3 relies on its interaction with Groucho/TLE 
corepressors and is independent of β-catenin.  Images of transduced keratinocytes 
expressing tet-inducible Tcf3, Tcf3ΔN, Tcf3ΔG 16 hrs after the initiation of migration 
assay with or without Dox. Black bar denotes 200µm.   
(C) Graph quantifying the area migrated by transduced cells treated with Dox relative to 
area migrated by cells treated with vehicle control. For each sample, over 30 non-
overlapping fields were measured at each timepoint; and each experiment was repeated 
twice. Data are mean ± s.e.m. **p<0.001. 
(D) Tcf3-induced cells secrete factors that promote cell migration. Keratinocytes from tet-
inducible Tcf3 (K14-rtTA;TRE-mycTcf3) and control (K14-rtTA) mice were cultured in the 
presence or absence of Dox for 48 hours and their conditioned media were collected.  
Wild type keratinocytes were subjected to a migration assay in the presence of specified 
conditioned media.  Images were taken 38hrs after the initiation of migration assay. 
(E) Conditioned media from Tcf3-induced cells (K14-rtTA;TRE-mycTcf3 +Dox) promotes 
migration of wild-type cells.  Graph quantifying the migrated area of wild-type cells that 
were incubated with Dox treated conditioned media during the migration assay relative 
to the area migrated by cells treated with vehicle treated conditioned media. For each 
sample, over 30 non-overlapping fields were measured at each timepoint; and each 
experiment was repeated three times.  Data are mean ± s.e.m.  **p<0.001. 
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Figure 6.  Lipocalin 2 is the key secreted mediator of Tcf3-induced cell migration 
and wound healing. 
(A) Images of skin wound sites taken immediately after wounding and 10 days post 
wounding show that topical application of CM from Tcf3 overexpressing cells (Tcf3-CM) 
accelerates wound healing.  After full-thickness wounds of 1cm2 were created on the 
dorsal skins of wild-type mice (n=5), CM from Tcf3-overexpressing cells or control cells 
was applied topically onto the wound sites daily for a week.  Surface areas of the 
wounds were measured at the initial time point and 10 days post wounding.   
(B) Graph quantifying the surface areas of the wounds as a percentage of the original 
wounds 10 days post wounding shows that CM from Tcf3-overexpressing cells (Tcf3-
CM) accelerates wound closure.  Data are mean ± s.e.m.  *p<0.05. 
(C) Tcf3 overexpression results in the induction of the secreted factor Lcn2.  Real Time 
PCR analysis of Lcn2 expression in keratinocytes that were transduced to express tet-
inducible Lef/Tcf members. Keratinocytes were transduced with GFP-tagged, tet-
inducible lentivectors carrying myc-tagged Lef/Tcf members. Transduced cells were 
isolated by fluorescent cell sorting and were treated with Dox or vehicle control for 24 
hours prior to being harvested for mRNA analysis.  
(D) Inhibition of Lcn2 decreases the ability of Tcf3-CM to affect cell migration.  Migration 
assays were performed on keratinocytes that were incubated with control CM or Tcf3-
CM together with anti-Lcn2 antibody or IgG isotype control.  Graph quantifying the 
relative area migrated by keratinocytes treated with Tcf3-CM incubated with IgG or anti-
Lcn2 normalized over area migrated by cells treated with control CM. For each sample, 
over 30 non-overlapping fields were measured at each timepoint; and each experiment 
was repeated twice.  Data are mean ± s.e.m. **p<0.001. 
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(E) Graph quantifying the surface areas of the wounds as a percentage of the original 
wounds 10 days post wounding shows that inhibition of Lcn2 decreases the ability of 
Tcf3-CM to promote wound healing.  1cm2 full-thickness wounds were created on dorsal 
skins of wild-type mice and were treated daily with topical application of conditioned 
media from control (empty vector) CM (cont-CM) (n=7) or Tcf3-CM untreated (n=7) or 
pre-incubated with antibodies against Lcn2 (n=8) or isotype control (n=6).   Surface 
areas of the wounds were measured at the initial time point and 10 days post wounding.   
Data are mean ± s.e.m. *p<0.05. 
(F) Lcn2 overexpression promotes cell migration.  Migration assays were performed on 
keratinocytes that were incubated with Lcn2-CM or control (empty vector) CM (cont). 
Graph quantifying the relative migrated area of keratinocytes treated with the indicated 
CM.  For each sample, over 30 non-overlapping fields were measured at each timepoint; 
and each experiment was repeated twice.  Data are mean ± s.e.m.  **p<0.001. 
(G) Lcn2 accelerates wound closure.  1cm2 full-thickness wounds were created on 
dorsal skins of wild-type mice (n=4) and were treated daily with topical application of 
conditioned media (CM) from Lcn2 or control (empty vector) transduced keratinocytes.   
Images of the wound sites were taken at the beginning of the wounding experiment and 
10 days post wounding, at which point skins were harvested for analysis.  
(H) Graph quantifying the effect of topical application of Lcn2-CM on wound closure. 
Average surface areas of the wounds 10 days post wounding is quantified as a 
percentage of the initial wound areas.  Areas of the wounds were measured with ImageJ 
software.  Data are mean s.e.m. *p<0.05. 
 
Figure 7. Lipocalin2 is required for efficient wound healing and can rescue 
defective wound healing in Stat3 cKO mice. 
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(A) Images of skin wound sites taken immediately after wounding and 11 days post 
wounding show that topical application of antibodies against Lcn2 retarded wound 
healing.  After full-thickness wounds of 1cm2 were created on the dorsal skins of nude 
mice (n=8), anti-Lcn2 or isotype control antibodies were applied topically onto the wound 
sites every other day.  Surface areas of the wounds were measured at the initial time 
point and 11 days post wounding.   
(B) Graph quantifying the surface areas of the wounds as a percentage of the original 
wounds 11 days post wounding shows that application of antibodies against Lcn2 
retards wound closure.  Data are mean ± s.e.m.  *p<0.05. 
(C) Inhibition of Lcn2 decreases the ability of Tcf3 to rescue defective migration in Stat3 
cKO keratinocytes.  Migration assays were performed on Stat3+/fl:K14-cre (cont) or 
Stat3fl/fl:K14-cre (Stat3 cKO) keratinocytes that were transduced with control or tet-
inducible Tcf3 treated with Dox together with anti-Lcn2 antibody or IgG isotype control.  
Graph quantifying the relative area migrated by keratinocytes normalized over area 
migrated by cells transduced with control vector without Dox. For each sample, over 30 
non-overlapping fields were measured at each timepoint; and each experiment was 
repeated twice.   Data are mean ± s.e.m.  **p<0.001. 
(D) Images of skin wound sites taken 10 days post wounding show that topical 
application of recombinant Lcn2 rescues defective wound healing in Stat3 cKO mice.  
After full-thickness wounds of 1cm2 were created on the dorsal skins of wild-type (n=13) 
and Stat3 cKO (n=11) mice, 200µl of recombinant Lcn2 (2µg/ml) or vehicle were applied 
topically onto the wound sites every other day.  Surface areas of the wounds were 
measured at the initial time point and 10 days post wounding.   
(E) Graph quantifying the surface areas of the wounds as a percentage of the original 
wounds 10 days post wounding shows that Lcn2 rescues wound closure defect in Stat3 
cKO mice.  Data are mean ± s.e.m.  *p<0.05  and **p<0.001. 
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